These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A, Markart P, Kalinowski M, Ruppert C, Grimminger F, Seeger W. Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [Abstract] [Full Text] [Related]
31. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M. Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093 [Abstract] [Full Text] [Related]
33. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y. J Cardiol; 1993 Jul; 23(4):335-41. PubMed ID: 8064582 [Abstract] [Full Text] [Related]
34. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Lwaleed BA, Greenfield R, Stewart A, Birch B, Cooper AJ. Thromb Haemost; 2004 Oct; 92(4):752-66. PubMed ID: 15467906 [Abstract] [Full Text] [Related]
35. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Laudes IJ, Chu JC, Sikranth S, Huber-Lang M, Guo RF, Riedemann N, Sarma JV, Schmaier AH, Ward PA. Am J Pathol; 2002 May; 160(5):1867-75. PubMed ID: 12000738 [Abstract] [Full Text] [Related]
36. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O, Rijken DC, Collen D. Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339 [Abstract] [Full Text] [Related]